SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (3017)11/27/1997 10:04:00 AM
From: Bhag Karamchandani  Read Replies (3) of 6136
 
Given the discussion on AGPH stock price, I would add the following for any one to check out the provocative hypothesis: Those who buy AGPH on good newslose money. Two examples: Typically for weeks before the two major press releases, from AGPH last year, first confirming Viracept's effectivenesss in a cocktail trial and the second announcing FDA approval, the stock price went up steadily prior to these announcements and then dropped sharply on the announcement. To a 'paranoid' this would suggest that there are some who are privy to 'highly reliable' rumours which allow them to take positions which get sold off on good news- when the average individual / retail customer usually buys in.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News